Isthmus Partners’s Biogen BIIB Stock Holding History

Isthmus Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-42	Closed	-$12K	–	262
2015 Q3	$12K	Hold	42	–	–	﹤0.01%	237
2015 Q2	$17K	Buy	+42	New	+$16.9K	0.01%	224

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Isthmus Partners's BIIB Position: Q4 2015 in Review

Isthmus Partners sold out of Biogen (BIIB) in Q4 2015, closing a stake of 42 shares — an estimated $12K sold.

Isthmus Partners first reported a position in BIIB in Q2 2015 and held it in 2 quarters. The position peaked at $17K in Q2 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

Isthmus Partners reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
Isthmus Partners sold 42 Biogen shares in Q4 2015, an estimated $12K.
Isthmus Partners first reported a position in Biogen in Q2 2015 and held it in 2 quarters.
Isthmus Partners's Biogen position peaked at $17K in Q2 2015.
970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Isthmus Partners's 13F filing for Q4 2015, filed 1 Feb 2016.